Sfoglia per AUTORE
SANDOR V
Collezione ASL Alessandria

  

Items : 1

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea in Cancer

2014
ASL Alessandria

Gattoni E; Pieri L; Guglielmelli P; Elena C; He S; Contel N; Mookerjee B; Sandor V; Cazzola M; Kantarjian HM; Barbui T; Vannucchi AM; Verstovsek S; Passamonti F; Rambaldi A; Barosi G; Rosen PJ; Rumi E;